Founded in 2021 and located in Suresnes, France, Phagos is a biotechnology research company specializing in AI-native phage therapy. The firm creates personalized bacterial treatments as a sustainable alternative to antibiotics.
Subscribe to see Phagos, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Phagos, Inc. is a biotechnology company headquartered in Suresnes, France. Its most recent funding round, Series A, raised $30M in October 2025. Xcout tracks 7 named people at Phagos, Inc., including Alexandros Pantalis (President).
As of 16 November 2026. Source: Xcout Intel.
1 more named person on record for Phagos, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $30M | 9 named | |
| SEC Form D filing | $7.6M | — | |
| — | $2.6M | 2 named | |
| SEC Form D filing | $1.5M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 11 named investors across 2 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of Phagos, Inc.'s closest competitors — see the full list of competitors and alternatives →
Kyron.bio is a Paris-based biotechnology startup using synthetic biology to refine biologic drug design and improve the yield, activity, and stability of new therapies.
Axitan Holdings is a biotechnology company that develops novel endolysin-based products to target and neutralize pathogenic bacteria for the animal protein and food safety industries. Its technology provides antibiotic-free solutions to help reduce antimicrobial resistance and address key productivity issues in poultry and livestock production.
ArrePath is a biotechnology research company based in Princeton, New Jersey, focusing on AI-enabled oral small-molecule discovery. The company uses proprietary artificial intelligence and machine learning workflows proven in antibacterial discovery.
Meddenovo Drug Design is a Lyon, France-based biotechnology company operating at the intersection of AI and life sciences to build advanced computational technologies for peptide drug discovery.
Pharos iBio Co., Ltd. is a South Korean biotechnology company that uses artificial intelligence and big-data approaches for drug discovery and development. Its pipeline includes oncology candidates such as PHI-101, a FLT3 inhibitor being developed for acute myeloid leukemia and other cancers, serving patients with difficult-to-treat diseases and pharmaceutical development partners.
Photys Therapeutics, Inc. is a proximity-based biotechnology holding company founded in 2021 and headquartered in Massachusetts, United States. The company focuses on discovering and developing novel targeted protein therapeutics.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Phagos, Inc.? Suggest a correction · Work at Phagos, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.